Quest Diagnostics (DGX) Depreciation & Amortization (CF) (2009 - 2026)

Quest Diagnostics has disclosed Depreciation & Amortization (CF) across 18 years of filings, most recently posting $147.0 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $147.0 million, up 5.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $577.0 million (up 11.61% YoY), and the FY2025 annual result was $570.0 million, up 15.62% from the prior year.
• Depreciation & Amortization (CF) came in at $147.0 million for Q1 2026 at Quest Diagnostics, up from $145.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $147.0 million in Q1 2026 to a low of $106.0 million in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $116.0 million (2022), against an average of $122.7 million.
• Across the five-year window, Depreciation & Amortization (CF) retreated 6.03% in 2023 and climbed 23.85% in 2024, its largest moves.
• Quest Diagnostics' Depreciation & Amortization (CF) stood at $116.0 million in 2022, then retreated by 6.03% to $109.0 million in 2023, then increased by 23.85% to $135.0 million in 2024, then grew by 7.41% to $145.0 million in 2025, then climbed by 1.38% to $147.0 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $147.0 million (Q1 2026), $145.0 million (Q4 2025), and $142.0 million (Q3 2025), per Business Quant data.